Do you take any precautions in planning PMRT for patients who had taxane-induced pneumonitis?
Assuming the patient has N2-3 disease, would you consider omitting IMN? What other techniques would you consider to limit lung exposure?
Answer from: Radiation Oncologist at Community Practice
The data regarding increase risk of radiation pneumonitis with Taxoil chemotherapy was more of a timing than lung volume issue. This risk was extremely high (>15%) when RT was given concomitant with radiation in the early days and also when it started close to the last cycle of taxol. We have not...